Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Knowing when to choose cash back over points on credit cards can save you money. Learn the scenarios that favor cash back!
27,373 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
As TopBuild (BLD) closes 2025, investors look for how revenue, margins, and backlog shape the 2026 outlook. This arti...
AI momentum has pushed markets higher, but one stock stands out as a potential tech stock with eyes. This piece break...
In a choppy market, a dependable income stock is turning heads in 2026. This article breaks down why this resilient d...
As markets wobble in mid-2026, a trio of NYSE dividend names stands out for safety and income. They combine durable c...
As Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
Two Harbors Investment Corp. says UWM Holdings failed to submit a revised bid or request more time as the negotiation...
Investing in Iron Mountain offers a blend of durable revenue and a meaningful dividend. This guide breaks down how th...
Investors are watching a potential shift at HubSpot as AI features expand across its platform. This guide breaks down...
Palantir has cooled off after a blazing run, but analysts say there's still meaningful upside. This guide breaks down...
Meta Platforms faces a choppy start to July 2026, but a fresh meta stock price prediction points to meaningful upside...
When mining stocks fall, investors want to know the why and what next. This guide breaks down the drivers behind hecl...